Internal Medicine · College Station, TX
NPI
1043449465
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1602 Rock Prairie Rd, Suite 210
College Station, TX, 77845
Phone (979) 696-5663
Groups this clinician bills Medicare through
Medicare paid, 2024
$49K
1,079 services
Medicare patients, 2024
132
Average age 71
Drug cost, 2024
$1.6M
3,136 prescriptions
Company payments, 2025
$1,148
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natraj A Shanmugam was code 99214 (office e&m - established), 409 times for 131 patients. In total Natraj A Shanmugam billed 1,079 services in 9 codes, and Medicare paid $49K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-02-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 409 | 131 | $82.75 | $34K |
| 83036 Blood Count | Office | 239 | 95 | $9.48 | $2,267 |
| 95251 Test - Miscellaneous | Office | 233 | 72 | $24.05 | $5,604 |
| 82947 Clinical Chemistry | Office | 103 | 54 | $3.82 | $393 |
| 95250 Test - Miscellaneous | Office | 30 | 26 | $100.19 | $3,006 |
| 99211 Office E&M - Established | Office | 20 | 16 | $14.00 | $280 |
| 95249 Test - Miscellaneous | Office | 16 | 16 | $39.21 | $627 |
| 99213 Office E&M - Established | Office | 15 | 13 | $49.87 | $748 |
| 99205 Office E&M - New | Office | 14 | 14 | $155.59 | $2,178 |
By year: 2022 $53K for 1,197 services; 2023 $57K for 1,208 services; 2024 $49K for 1,079 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 239 | 95 | $9.48 | $2,267 |
| 82947 Clinical Chemistry | 103 | 54 | $3.82 | $393 |
Medicare prescription drug claims, 2024
In 2024, the drug Natraj A Shanmugam prescribed most often to Medicare patients was Ozempic (Semaglutide), with 331 prescriptions and refills. In total Natraj A Shanmugam wrote 3,136 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 331 | 558 | 78 | $544K |
| Metformin Hcl Er Metformin Hcl | 184 | 473 | 52 | $2,043 |
| Levothyroxine Sodium Generic | 167 | 455 | 49 | $1,459 |
| Synthroid Levothyroxine Sodium | 160 | 360 | 44 | $14K |
| Jardiance Empagliflozin | 138 | 279 | 41 | $163K |
| Rosuvastatin Calcium Generic | 91 | 264 | 29 | $1,017 |
| Mounjaro Tirzepatide | 79 | 101 | 13 | $107K |
| Pioglitazone Hcl Generic | 69 | 179 | 18 | $646 |
| Humalog Insulin Lispro | 63 | 117 | 21 | $20K |
| Farxiga Dapagliflozin Propanediol | 62 | 112 | 13 | $62K |
| Tradjenta Linagliptin | 59 | 94 | 13 | $47K |
| Tresiba Flextouch U-200 Insulin Degludec | 58 | 87 | 14 | $49K |
| Amlodipine Besylate Generic | 51 | 151 | 15 | $174 |
| Novolog Insulin Aspart | 50 | 89 | 16 | $22K |
| Tresiba Flextouch U-100 Insulin Degludec | 49 | 86 | 19 | $25K |
Brand drugs: 1,670 claims; generic drugs: 1,235 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natraj A Shanmugam $1,148 ($1,148 in general payments such as food, travel and fees) from 12 companies. The largest payer was Novo Nordisk Inc with $471.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 13 | $471 |
| Insulet Corporation PODD | 12 | $167 |
| Medtronic, Inc. MDT | 12 | $159 |
| Dexcom, Inc. DXCM | 4 | $134 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $54.74 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $36.87 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $27.24 |
| Sequel Med Tech, LLC | 1 | $25 |
| IBSA Pharma Inc. | 1 | $19.68 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $18.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.